ProQR Therapeutics (PRQR) EPS (Basic) Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 22.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.15% |
| Sep 30, 2025 | -2.10% |
| Jun 30, 2025 | -20.36% |
| Mar 31, 2025 | -13.99% |
| Dec 31, 2024 | -106.29% |
| Sep 30, 2024 | -19.73% |
| Jun 30, 2024 | 14.47% |
| Mar 31, 2024 | -19.05% |
| Dec 31, 2023 | 37.37% |
| Sep 30, 2023 | -2.49% |
| Jun 30, 2023 | -53.05% |
| Mar 31, 2023 | -6,271.21% |
| Dec 31, 2022 | 22.83% |
| Sep 30, 2022 | -37.76% |
| Jun 30, 2022 | -25.78% |
| Mar 31, 2022 | -21.51% |
| Dec 31, 2021 | 13.81% |
| Sep 30, 2021 | -38.72% |
| Jun 30, 2021 | -36.97% |
| Mar 31, 2021 | -5,284.66% |
| Dec 31, 2020 | -36.76% |
| Sep 30, 2020 | -6,230.95% |
| Jun 30, 2020 | 4.92% |
| Mar 31, 2020 | -25.99% |
| Dec 31, 2019 | 3.13% |
| Sep 30, 2019 | -2,956.57% |
| Jun 30, 2019 | -3,358.92% |
| Mar 31, 2019 | -4,605.64% |
| Dec 31, 2018 | -13.14% |
| Sep 30, 2018 | -2,998.91% |
| Jun 30, 2018 | -3,166.86% |
| Mar 31, 2018 | 25.99% |
| Dec 31, 2017 | 92.15% |
| Sep 30, 2017 | 29.77% |
| Mar 31, 2017 | 4,229.50% |
| Dec 31, 2016 | 94.85% |
| Sep 30, 2016 | 94.70% |